Insider Trading activities of Inhibitor Therapeutics, Inc. (INTI)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inhibitor Therapeutics, Inc. (INTI) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inhibitor Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Inhibitor Therapeutics, Inc. since 2005. The reporting company's ticker symbol is INTI. The reporting company's CIK number is 1042418.
The total value of stock buying since 2005 is $195,192,046,286.
The total value of stock sales since 2005 is $3,447,957.
The total value of stock option exercises since 2005 is $14,999.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Inhibitor Therapeutics, Inc. (INTI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-12 13,500 $945 0 $0 0 $0
2018-08 0 $0 100,000 $27,000 0 $0
2017-12 1,200,000 $195,192,000,000 0 $0 0 $0
2017-06 0 $0 2,500,000 $0 0 $0
2017-03 0 $0 0 $0 24,291,738 $0
2016-06 0 $0 10,240,000 $0 0 $0
2015-09 20,000,000 $0 20,000,000 $0 0 $0
2014-09 10,000 $1,300 0 $0 0 $0
2010-01 0 $0 19,100 $9,550 0 $0
2009-05 45,610 $16,699 0 $0 0 $0
2009-04 19,706 $6,897 0 $0 0 $0
2008-09 5,000 $4,900 2,150,000 $3,117,500 0 $0
2008-05 0 $0 10,000 $15,850 0 $0
2008-04 0 $0 4,000 $11,560 0 $0
2006-12 0 $0 12,000 $30,876 11,029 $14,999
2006-07 0 $0 32,000 $88,419 0 $0
2006-05 2,000 $5,200 0 $0 0 $0
2006-04 2,000 $6,450 0 $0 0 $0
2006-01 0 $0 6,500 $30,290 0 $0
2005-12 0 $0 1,000 $4,920 0 $0
2005-10 0 $0 10,000 $43,000 0 $0
2005-09 0 $0 15,000 $65,040 0 $0
2005-05 0 $0 1,000 $3,952 0 $0
2005-04 1,000 $3,895 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Inhibitor Therapeutics, Inc. insiders (INTI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-12-02 Hasara Garrison J. (CFO and Treasurer) Buy 13,500 .07 945
2018-08-30 Hasara Garrison J. (CFO and Treasurer) Sale 100,000 .27 27,000
2017-12-19 Cross Stefan Buy 600,000 162,660.00 97,596,000,000
2017-12-19 Mayne Pharma Group Ltd Buy 600,000 162,660.00 97,596,000,000
2017-06-30 Hedgepath, Llc (10% Owner) Sale 2,500,000 .00 0
2017-03-08 Watson W. Mark (Director) Option Ex 900,000 .00 0
2017-03-08 Cross Stefan (Director) Option Ex 600,000 .00 0
2017-03-08 Ono Richard Dana (Director) Option Ex 750,000 .00 0
2017-03-08 Hasara Garrison J. (CFO and Treasurer) Option Ex 7,000,000 .00 0
2017-03-08 Virca Nicholas J (President and CEO) Option Ex 15,041,738 .00 0
2016-06-15 Hedgepath, Llc (10% Owner) Sale 5,120,000 .00 0
2016-06-15 Odonnell Francis E Jr (Executive Chairman) Sale 2,560,000 .00 0
2015-09-10 Hedgepath, Llc (10% Owner) Sale 20,000,000 .00 0
2015-09-10 Odonnell Francis E Jr (Executive Chairman) Buy 20,000,000 .00 0
2014-09-08 Watson W. Mark (Director) Buy 10,000 .13 1,300
2010-01-19 D'sylva Paul (Director) Sale 19,100 .50 9,550
2009-05-29 D'sylva Paul (Director) Buy 12,000 .40 4,800
2009-05-15 D'sylva Paul (Director) Buy 510 .38 193
2009-05-14 D'sylva Paul (Director) Buy 2,800 .40 1,120
2009-05-05 D'sylva Paul (Director) Buy 23,934 .35 8,376
2009-05-04 D'sylva Paul (Director) Buy 500 .35 175
2009-05-01 D'sylva Paul (Director) Buy 5,866 .35 2,035
2009-04-30 D'sylva Paul (Director) Buy 19,706 .35 6,897
2008-09-25 Freer Richard J (COO) Buy 5,000 .98 4,900
2008-09-12 Pharmaust Chemistry Ltd. (10% Owner) Sale 2,150,000 1.45 3,117,500
2008-05-27 Harris Robert B (President) Sale 10,000 1.58 15,850
2008-04-11 Reynolds Thomas R (Secretary) Sale 4,000 2.89 11,560
2006-12-22 Freer Richard J (Chairman & COO) Option Ex 11,029 1.36 14,999
2006-12-08 Sears Samuel P Jr (Director) Sale 12,000 2.57 30,876
2006-07-14 Sears Samuel P Jr (Director) Sale 16,500 2.72 44,830
2006-07-11 Sears Samuel P Jr (Director) Sale 2,500 2.76 6,899
2006-07-10 Sears Samuel P Jr (Director) Sale 3,000 2.83 8,490
2006-07-07 Sears Samuel P Jr (Director) Sale 10,000 2.82 28,200
2006-05-15 Krueger Gerald P (Director) Buy 2,000 2.60 5,200
2006-04-19 Krueger Gerald P (Director) Buy 1,000 3.25 3,250
2006-04-07 Freer Richard J (COO and Chairman) Buy 1,000 3.20 3,200
2006-01-10 Sears Samuel P Jr (Director) Sale 6,500 4.66 30,290
2005-12-27 Sears Samuel P Jr (Director) Sale 1,000 4.92 4,920
2005-10-24 Sears Samuel P Jr (Director) Sale 10,000 4.30 43,000
2005-09-30 Sears Samuel P Jr (Director) Sale 3,000 4.40 13,200
2005-09-22 Sears Samuel P Jr (Director) Sale 12,000 4.32 51,840
2005-05-25 Brennan James H (Controller) Sale 1,000 3.95 3,952
2005-04-15 Krueger Gerald P (Director) Buy 1,000 3.90 3,895

Insider trading activities including stock purchases, stock sales, and option exercises of INTI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inhibitor Therapeutics, Inc. (symbol INTI, CIK number 1042418) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month